Solana shows strong long-term potential due to fast performance and growing blockchain adoption. XRP maintains a higher market value supported by payment-focused utility and regulatory clarity. Both tokens could shift positions by 2030, depending on real adoption, market trends, and gaming or NFT growth.
XRP price is near $2.13 at press time, and its circulating market capitalisation is close to $128 billion. Solana price is hovering between $143 and $160, with a market capitalisation of about $103.8 billion based on early-November 2025 market data. These figures show that XRP currently holds a higher overall value in the market, even though each Solana token is priced far higher than each XRP token.
The most important measure that will ensure complete value growth is market capitalization. Token price is misleading, given that different cryptocurrencies have very different circulating supplies. XRP has a huge circulating supply, whereas Solana's supply is much smaller. That's why its price per coin is so high, but in total market value, it still lags behind XRP. At the moment, XRP is still ahead in terms of total value, but Solana is close enough that a future shift is possible.
“XRP maintains a higher market value supported by payment-focused utility and regulatory clarity. Both tokens could shift positions by 2030, depending on real adoption, market trends, and gaming or NFT growth.”
Solana could overtake XRP if its ecosystem continues to grow rapidly, institutional investment increases, and new applications (including gaming and NFTs) expand its use cases. XRP could retain leadership if banks and institutions broadly adopt its payment-oriented capabilities and regulatory clarity remains favorable. The eventual ranking by 2030 will hinge on actual adoption patterns, market dynamics, and the evolution of both ecosystems.
ANALYSIS SUMMARY: The near-term lead belongs to XRP on total market value, but Solana’s rapid ecosystem expansion keeps a credible path to overtaking XRP by 2030 if adoption and investment accelerate.